Moxeza 0.5 % Ophthalmic Solution
RxNorm 1047508
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1047508 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Moxeza 0.5 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSN
Prescribable Name (PSN):
Moxeza 0.5 % Ophthalmic Solution
(Atom ID: 6398389)
SY
Synonym (SY):
Moxeza 0.5 % Ophthalmic Solution
(Atom ID: 3520916)
SY
Synonym (SY):
Moxeza 5 mg/ML (moxifloxacin hydrochloride 5.45 mg/ML) Ophthalmic Solution
(Atom ID: 3611022)
SY
Synonym (SY):
Moxeza 5 mg/ML Ophthalmic Solution
(Atom ID: 3520915)
SBD
Semantic Branded Drug (SBD):
Moxifloxacin 5 mg/ML Ophthalmic Solution [Moxeza]
(Atom ID: 3520914)
Patient Education
Moxifloxacin Ophthalmic
Moxifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pink eye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids). Moxifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infection.
[Learn More]
* Please review the disclaimer below.